STEAP4 with copper reductase activity suppresses tumorigenesis by regulating the cell cycle in hepatocellular carcinoma cells

Table 1 Association of STEAP4 expression with clinicopathological characteristics in TCGA-liver hepatocellular carcinoma (LIHC) patients

Factors	n = 371	High groups (n = 186)	Low groups (n = 185)	P*
Gender
Male	250	131	119	0.210
Female	121	55	66
Ages(years)
21–40	34	17	17	0.931
41–60	143	72	71
61–80	183	93	90
81–100	10	4	6
NA	1
Tumor Stage
T1	181	103	78	0.024
T2	94	41	53
T3	80	32	48
T4	13	7	6
TX	1	1	0
NA	2
Lymph Node Stage
N0	252	121	131	0.212
N1	4	1	3
Nx	114	64	50
Meteastasis Stage
M0	266	124	142	0.079
M1	4	3	1
Mx	101	59	42
Race Category
White	183	107	76	0.012
Asian	158	64	94
Other	20	10	10
NA	10	5	5
BMI
<18.5	21	7	14	0.133
18.5–24.9	156	76	80
25–29.9	90	43	47
30–34.9	37	19	18
35–39.9	20	15	5
≥40	11	7	4
NA	36	19	17

ISSN: 1747-1028